Literature DB >> 26862027

Endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation.

Yuhei Suzuki1, Yuichi Yamazaki2, Hiroaki Hashizume1, Takeshi Kobayashi1, Tatsuya Ohyama1, Norio Horiguchi1, Ken Sato1, Satoru Kakizaki1, Motoyasu Kusano3, Masanobu Yamada1.   

Abstract

A 54-year-old male consulted a local doctor with a chief complaint of systemic convulsions and muscle stiffness and was diagnosed with Isaacs' syndrome based on positive findings for antibodies against voltage-gated potassium channels in 2009. He subsequently experienced repeated hematemesis in 2013, at which time he was taken to our hospital by ambulance. Emergent endoscopy revealed esophageal varices with spurting bleeding. The bleeding was stopped with urgent endoscopic variceal ligation. Three days later, the patient developed sudden dyspnea with stridor during inspiration under sedation with an intravenous injection of low-dose flunitrazepam prior to receiving additional treatment and was aroused with intravenous flumazenil, after which his dyspnea immediately improved. Dyspnea may be induced by muscle cramps associated with Isaacs' syndrome exacerbated by sedation. Endoscopic variceal ligation was performed safely using multiple ligation devices in an awake state following pre-medication with hydroxyzine, without sudden dyspnea. Endoscopists should be cautious of the use of sedatives in patients with diseases associated with muscle twitching or stiffness, as in the current case. In addition, it is necessary to administer endoscopic treatment in an awake state or under conscious sedation in patients with a high risk of dyspnea.

Entities:  

Keywords:  Dyspnea; Endoscopic treatment; Isaacs' syndrome; Muscle cramps; Sedation

Mesh:

Year:  2016        PMID: 26862027     DOI: 10.1007/s12328-016-0626-y

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  10 in total

Review 1.  Optimal sedation for gastrointestinal endoscopy: review and recommendations.

Authors:  Andrew Thomson; Gabrielle Andrew; D Brian Jones
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

2.  A SYNDROME OF CONTINUOUS MUSCLE-FIBRE ACTIVITY.

Authors:  H Isaacs
Journal:  J Neurol Neurosurg Psychiatry       Date:  1961-11       Impact factor: 10.154

3.  Clinical evaluation of plasma exchange and high dose intravenous immunoglobulin in a patient with Isaacs' syndrome.

Authors:  A Ishii; A Hayashi; N Ohkoshi; E Oguni; M Maeda; Y Ueda; K Ishii; K Arasaki; H Mizusawa; S Shoji
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

4.  Acquired neuromyotonia and peripheral neuropathy in a patient with Hodgkin's disease.

Authors:  H Lahrmann; G Albrecht; M Drlicek; S Oberndorfer; S Urbanits; J Wanschitz; U A Zifko; W Grisold
Journal:  Muscle Nerve       Date:  2001-06       Impact factor: 3.217

Review 5.  Neuromyotonia.

Authors:  Paul Maddison
Journal:  Clin Neurophysiol       Date:  2006-07-14       Impact factor: 3.708

6.  Anesthetic experience using total intravenous anesthesia in a patient with Isaacs' syndrome -A case report-.

Authors:  Young Mi Kim; Sang Hoon Lee; Cheol Sig Han; Eun Mi Choi; Young Ryong Choi; Mi Hwa Chung
Journal:  Korean J Anesthesiol       Date:  2013-02-15

7.  Isaacs syndrome with laryngeal involvement: an unusual presentation of myokymia.

Authors:  D L Jackson; S Satya-Murti; L Davis; D B Drachman
Journal:  Neurology       Date:  1979-12       Impact factor: 9.910

8.  Phenotypic variants of autoimmune peripheral nerve hyperexcitability.

Authors:  Ian K Hart; Paul Maddison; John Newsom-Davis; Angela Vincent; Kerry R Mills
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

9.  Syndrome of continuous muscle-fiber activity: increased CSF GABA and effect of dantrolene.

Authors:  T Sakai; S Hosokawa; H Shibasaki; I Goto; Y Kuroiwa; H Sonoda; Y Murai
Journal:  Neurology       Date:  1983-04       Impact factor: 9.910

10.  Low-dose flunitrazepam for conscious sedation for EGD: a randomized double-blind placebo-controlled study.

Authors:  Takashi Yoshizawa; Hiroto Miwa; Takayo Kojima; Yoshiaki Kawakubo; Akihiro Namihisa; Keiichi Ohtaka; Ryuichi Ohkura; Youko Nishira; Eiko Toriumi; Teruo Nishira; Nobuhiro Sato
Journal:  Gastrointest Endosc       Date:  2003-10       Impact factor: 9.427

  10 in total
  2 in total

1.  Safety Assessment of Liver Injury with Quetiapine Fumarate XR Management in Very Heavy Drinking Alcohol-Dependent Patients.

Authors:  Vatsalya Vatsalya; Akash Pandey; Melanie L Schwandt; Matthew C Cave; Shirish S Barve; Vijay A Ramchandani; Craig J McClain
Journal:  Clin Drug Investig       Date:  2016-11       Impact factor: 2.859

2.  Effect of dexmedetomidine in the prophylactic endoscopic injection sclerotherapy for oesophageal varices: a study protocol for prospective interventional study.

Authors:  Hiroki Nishikawa; Yoshinori Iwata; Akio Ishii; Hirayuki Enomoto; Yukihisa Yuri; Noriko Ishii; Yuho Miyamoto; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Journal:  BMJ Open Gastroenterol       Date:  2017-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.